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Abstract: Cardiovascular diseases (CVDs) represent a major concern in today’s society, with more
than 17.5 million deaths reported annually worldwide. Recently, five metabolites related to the gut
metabolism of phospholipids were identified as promising predictive biomarker candidates for CVD.
Validation of those biomarker candidates is crucial for applications to the clinic, showing the need
for high-throughput analysis of large numbers of samples. These five compounds, trimethylamine
N-oxide (TMAO), choline, betaine, l-carnitine, and deoxy-l-carnitine (4-trimethylammoniobutanoic
acid), are highly polar compounds and show poor retention on conventional reversed phase
chromatography, which can lead to strong matrix effects when using mass spectrometry detection,
especially when high-throughput analysis approaches are used with limited separation of analytes
from interferences. In order to reduce the potential matrix effects, we propose a novel fast parallel
electromembrane extraction (Pa-EME) method for the analysis of these metabolites in plasma samples.
The evaluation of Pa-EME parameters was performed using multi segment injection–capillary
electrophoresis–mass spectrometry (MSI-CE-MS). Recoveries up to 100% were achieved, with
variability as low as 2%. Overall, this study highlights the necessity of protein precipitation prior to
EME for the extraction of highly polar compounds. The developed Pa-EME method was evaluated in
terms of concentration range and response function, as well as matrix effects using fast-LC-MS/MS.
Finally, the developed workflow was compared to conventional sample pre-treatment, i.e., protein
precipitation using methanol, and fast-LC-MS/MS. Data show very strong correlations between both
workflows, highlighting the great potential of Pa-EME for high-throughput biological applications.
Keywords: electromembrane extraction; cardiovascular disease; multi-segment injection; capillary
electrophoresis–mass spectrometry; liquid chromatography–mass spectrometry
1. Introduction
With 17.5 million deaths per year, cardiovascular disease (CVD) represents the leading cause
of death worldwide and is thus considered a major public health issue [1]. Gut flora-dependent
metabolism has been recently reported as a risk factor for CVD, most notably the metabolic pathway
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for dietary phosphatidylcholine which includes trimethylamine oxide (TMAO), choline, betaine,
l-carnitine, and deoxy-l-carnitine. These metabolites are related to the development of various CVDs
including stroke and myocardial dysfunction [2–5].
Mass spectrometry (MS) coupled with separation techniques is a widely used tool in metabolomics,
enabling the identification and quantitation of metabolites via the analysis of thousands of samples.
Hydrophilic interaction chromatography (HILIC)-based methods allow for an efficient separation of
polar compounds such as the ones involved in the dietary phosphatidylcholine metabolic pathway,
but they require long re-equilibration times, resulting in low throughput [6]. Fast chromatography is
often preferred in combination with fast sample pre-treatment. However, this approach may lead to
significant matrix effects (MEs), i.e., the alteration of the analyte signal due to the presence of co-eluting
matrix interference. Deuterated internal standards (dISTDs) can be added to correct for the deleterious
effect of ME on quantitation. However, even though quantitative corrections can be applied, ion
suppression will still lead to decreased signal intensity and lower sensitivity, showing the need for
alternative approaches.
In order to reduce MEs, a sample preparation step is highly recommended. The most common
practice in metabolomics is to remove proteins by protein precipitation [7] or ultrafiltration [8]. However,
these two approaches cannot separate the compounds of interest from interferences such as salts or
phospholipids [9,10]. To do this, more complex sample preparation approaches, e.g., liquid–liquid
extraction or reversed phase solid phase extraction are often considered. However, in the present case
the metabolites of interest are quaternary ammoniums. Therefore, only weak cation exchanger resins
are conceivable. However, this extraction mode is complicated and expensive.
Electromembrane extraction (EME) is a recently developed electro-driven sample preparation
method developed for the extraction of charged compounds [11]. In this approach, two compartments,
namely, the donor and acceptor compartments, are separated by a supported liquid membrane (SLM)
containing an organic solvent. When applying an electric field between the two compartments, the
ions present in the donor compartment are selectively extracted to the acceptor compartment [12,13].
With this approach, it is possible to reach very high recovery (up to 100%) and enrichment factor (up to
50-fold) in a few minutes [14,15]. In addition, this method allows for an efficient sample clean-up by
separation of metabolites of interest from phospholipids and salts, as well as proteins [16–18]. EME
has extensively been applied to the extraction of non-polar and moderately polar drugs (1 < logP < 5).
Recent work has also demonstrated the great potential of EME for the extraction of highly polar
compounds (logP < −1) [19–22]. TMAO, choline betaine, l-carnitine, and deoxy-l-carnitine, as
quaternary ammonium compounds, are excellent candidates for EME due to their permanent positive
charge. Indeed, acylcarnitines have been already successfully extracted by electroextraction [23–25].
However, the EME set-ups described are not suited for high throughput workflows necessary for large
cohort studies.
In this study, we developed and optimized a parallel EME (Pa-EME) extraction method for the
these five metabolites from human plasma samples. This approach enabled the extraction from several
samples in parallel, dramatically increasing the extraction throughput. A non-polar drug, bupivacaine,
was also added to the set of selected compounds to monitor the extraction process. The influence
of the applied voltage as well as the composition of the donor compartment were investigated.
For method optimization, the extracted compounds were analyzed using a multi segment-capillary
electrophoresis-mass spectrometry (MSI-CE-MS) method to both improve the throughput of the analysis
and reduce the analytical variability. The optimized method was then combined with fast-liquid
chromatography–tandem mass spectrometry (Fast-LC-MS/MS) for further evaluation of response
function and dynamic range. ME was evaluated by comparing the developed extraction method
to a sample pre-treatment method conventionally used in metabolomics, i.e., protein precipitation
using methanol (PP-MeOH) [26,27]. Finally, the developed EME-LC-MS/MS method was applied to
the analysis of 40 plasma samples and compared to PP-MeOH to show the strength of the method.
Metabolites 2020, 10, 4 3 of 17
This highlighted the relevance of such approaches for large-scale metabolomics studies, where the
analysis of highly polar metabolites in complex matrices remains challenging.
2. Experimental
2.1. Chemical and Reagents
MS-grade acetic acid and sodium hydroxide (≥ 99%) were purchased from VWR International BV
(Amsterdam, The Netherlands). MS-grade methanol (MeOH), isopropanol (iPrOH), and acetonitrile
(MeCN) were supplied from Actu-All Chemicals (Oss, the Netherlands). Model compounds
(purity ≥ 95%) as well as 6.1 N trichloroacetic acid (TCA) and 2-nitrophenyl pentyl ether (NPPE, ≥ 99%)
were purchased from Sigma-Aldrich Chemie NV (Zwijndrecht, The Netherlands). Deuterated internal
standards (dISTDs), isotopic purity ≥ 99%, were purchased from Cambridge Isotopes Laboratories, Inc.
(Tewksbury, MA, USA), except TMAO-d9 (CDM Isotopes, Pointe-Claire, Quebec, Canada). MS-grade
formic acid (FA) and 37% (v/v) hydrochloric acid were obtained from Thermo Fisher Acros Organics
(Geel, Belgium)
2.2. Preparation of Standard Solutions
Individual stock solutions of both standard and deuterated internal standard (dISTD) were
prepared in water/MeCN/FA (94.9:5:0.1, v/v) to reach a final concentration of 5 mg/mL. The method
development was performed using neat standards of carnitine-d3, deoxycarnitine-d9, choline-d4,
betaine-d9, TMAO-d9, and bupivacaine prepared in 5% MeCN and 0.1% FA at 100 µg/mL. This mixture
was diluted in the donor solution to a final concentration of 2.5 µg/mL before use. The acceptor solution
consisted of a solution of 1% acetic acid.
In addition, for MeOH for protein precipitation, dISTD solutions were also prepared in MeOH at
the following concentrations: 4 µg/mL for carnitine-d3, 0.2 µg/mL for deoxycarnitine-d9, 2 µg/mL for
choline-d4, 4 µg/mL for betaine-d9, and 0.3 µg/mL for TMAO-d9.
2.3. Plasma Samples
The method development was carried out using citrate plasma samples collected from eight
healthy volunteers obtained from Sanquin (Amsterdam, The Netherlands) and pooled together.
The method comparison was performed with 40 plasma samples collected from healthy volunteers
from the Growing Old Together (GOTO) study [28].
2.4. Sample Preparation: Protein Precipitation
In order to enhance extraction performance of Pa-EME, three different PP methods were
investigated during this study, namely, (1) PP using 6.1 N TCA (referred to as PP-TCA), (2) adjusted
PP-TCA, and (3) PP using MeOH with a ratio MeOH/sample of 9:1 ratio (referred to as PP-MeOH).
The resulting solutions were used as donor solution during the Pa-EME procedure.
The PP-TCA was performed using a solution of 6.1 N TCA with a ratio of 0.05:1 (TCA/sample, v/v).
Briefly, 25 µL of 6.1 N TCA were added to 475 µL of plasma. After 30 min of agitation at 1400 rpm at
23 ◦C using a Thermomixer (Vaudaux-Eppendorf AG, Bale, Switzerland), the sample was centrifuged
at 15,000 rpm for 15 min at 4 ◦C. Supernatant was then collected. In order to avoid potential variability,
multiple PPs were performed and their supernatants were mixed together prior to further division
into aliquots. Aliquots were then kept at −20 ◦C until analysis. As a donor solution for Pa-EME, the
aliquots were then diluted with adequate volume of water to reach an equivalent concentration of 10,
20, and 50% of untreated plasma, respectively.
This PP-TCA method was then adapted for the analysis of the 40 different plasma samples due to
the small volume of sample available, i.e., ca. 25 µL. Briefly, 20 µL of plasma were mixed with 20 µL of
dISTD solution. Then, 2 µL of 6.1 N TCA were added to obtain a final ratio of TCA/sample of 0.05:1
(v/v). After agitation at 1400 rpm for 30 min at 23 ◦C, 358 µL of water was added prior to centrifugation
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at 24,400× g during 20 min at 4 ◦C. The supernatant was then collected and stored at −20 ◦C prior to
electroextraction. For EME, 300 µL of the supernatant was used, leading to an equivalent untreated
plasma content of 5% in the donor compartment.
The third method, namely, PP-MeOH, was performed using 90 µL of MeOH containing dISTD
added to 10 µL of plasma. After vortex agitation for 1 min, samples were centrifuged for 5 min at
18,300× g. The supernatant was then collected, leading to a corresponding concentration of 10% of
untreated plasma in the analyzed sample.
2.5. Pa-EME Set-Up and Procedure
The electroextraction procedure and the Pa-EME device used in this study have been already
described elsewhere [28]. Briefly, the Pa-EME device consisted of a donor and an acceptor 96 well-plate,
as is illustrated in Figure 1. The acceptor plate consists of a custom made conductive 96 well-plate
in polyether ether ketone (PEEK) polymer. Conductivity was ensured by a piece of aluminum foil
with a thickness of 0.14 mm placed on the bottom of the well plate. In order to limit carryover and
cross contamination, the donor plate used was a disposable MultiScreen-IP Filter Plate of 300 µL with
a polyvinyldifluoride (PVDF) membrane with a thickness of 100 to 145 µm and a pore size of 0.45 µm,
and purchased from Millipore (Milford, MA, USA).
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Elektronica (Zierikzee, the Netherlands). After 15 min, the power supply was turned off, needles 
were removed from the acceptor plate, and both plates were separated. Finally, the extracts present 
in the acceptor compartment are collected and were ready to be analyzed. 
Figure 1. c ti re rese t ti f the paral el electro e brane extraction (Pa-E E) device.
Reprinted with permission [29]. SLM: supported liqui membrane; PAMPA: arallel artifici l membrane
permeability assay; PVDF: polyvinyldifluoride.
Impregnation of the PVDF membrane was performed by pipetting 3 µL of 2-nitrophenylpentyl
ether (NPPE) on the external face of the PVDF. Then, the excess of SLM is removed by placing the
plate on a tissue and by application of a 2.5 psi for 5s in each well using a positive pressure manifold
(Biotage, Uppsala, Sweden). This cleaning step was repeated until the tissue appeared dry. The donor
compartment was then filled with 300 µL of sample and was sealed using an adhesive sealing film
(PCR-TS, Axygen, MA, USA).
After filling of the acceptor plate with 300 µL of acceptor solution made of 1% acetic acid, the
donor plate was inserted into the acceptor one and the Pa-EME system was placed on a thermomixer
for agitation. The electrode needles were then inserted in the donor compartment. Extraction took
place for 15 min at 1400 rpm, with application of a constant voltage or current between the needles
and the aluminum foil of the conductive well-plate using a Power Supply ES 0300–0.45 from Delta
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Elektronica (Zierikzee, the Netherlands). After 15 min, the power supply was turned off, needles were
removed from the acceptor plate, and both plates were separated. Finally, the extracts present in the
acceptor compartment are collected and were ready to be analyzed.
In order to avoid potential carry over, the donor plate was discarded after use and the acceptor plate
was rinsed with a mixture of iPrOH/H2O 50:50 (v/v) and dried under nitrogen after each experiment.
2.6. Capillary Electrophoresis–Mass Spectrometry
CE separations were carried out using a G7100 capillary electrophoresis (CE) system from
Agilent (Waldbronn, Germany) using a fused silica capillary (BGB Analytik Benelux B.V, Harderwijk,
The Netherlands) with a length of 90 cm and an internal diameter of 50 µm. Separation was carried out
using a background electrolyte (BGE) composed of 10% acetic acid (v/v). Prior to first use, the capillary
was conditioned with MeOH, H2O, 1 M NaOH, H2O, 1 M HCl, H2O, 0.1 M HCl, H2O, and BGE at
5 bar. Between each run, the capillary was rinsed with MeOH and BGE at 5 bar for 130 s. CE-MS
analyses were performed using a MSI-CE-MS approach with electrokinetic plugs between samples
which were hydrodynamically injected [20]. Briefly, the first sample was hydrodynamically injected at
100 mbar for 20 s (corresponding to 1.6% of total length of the capillary). Prior to the second sample
injection, a voltage of +30 kV was applied during 60 s. This process was repeated until 7 samples were
injected. Typically, the first sample injected consisted of the neat standard at 2.5 µg/mL, followed by six
injections of other samples consisting of the replicates of a specific extraction condition. The samples
were kept at 7–8 ◦C in the auto-sampler using an external water cooling system.
The CE system was hyphenated with an Agilent 6230 TOF mass spectrometer (Santa Clara, CA,
USA) via an electrospray ionization (ESI) source and a coaxial sheath-flow ESI interface equipped
with a stainless-steel triple-tube sprayer (P/N G1607A) from Agilent Technologies. The sheath liquid
was composed of a mixture of H2O/iPrOH/acetic acid 50:50:1 (v/v/v) and delivered at a flow rate of
3 µL/min using a 2300 Series isocratic pump (Agilent Technologies) equipped with a 1:100 split ratio.
MS experiments were acquired in positive mode between 50 and 1000 m/z with an acquisition rate of
1.5 spectrum/s. The nebulizer gas was set to 0 psi, while the sheath gas flow rate and temperature
were set at 11 L/min and 100 ◦C, respectively. The ESI capillary voltage was adjusted to 5500 V.
Fragmentor and skimmer voltages were set at 150 V and 50 V, respectively. MassHunter version B.06.00
(Agilent, Santa Clara, CA, USA) was used for data acquisition, instrument control, and data treatment.
Isopropanol acetate adduct [CH3COOH-C3H8O+H]+ (m/z 121.08592) was used as reference mass for
TOF calibration of each spectrum.
2.7. Fast-Liquid Chromatography–Mass Spectrometry
A previously developed fast LC-MS/MS method for analysis of metabolites linked to gut
metabolism was used in this study [10]. Briefly, a 1290 Infinity II ultra-high pressure liquid
chromatography (UHPLC) system from Agilent Technologies (Waldbronn, Germany) was used
for fast LC-MS/MS experiments. The instrument was equipped with an autosampler, a column oven
and a binary pump with a maximum delivery flow rate of 5 mL/min. Separations were performed
with a Waters AccQ-TagTM Ultra column (2.1 mm × 100 mm, 1.7 µm) maintained at 60 ◦C. The mobile
phases consisted of 0.1% formic acid (A) and MeCN (B). The injection volume was 1 µL and the flow
rate of the mobile phase was set at 0.7 mL/min.
The separation was carried out using the following gradient: (B) maintained at 5% for 0.8 min,
further increased to 50% over 0.05 min, followed by an increase to 100% in 0.1 min. These conditions
were kept during 1.25 min before returning to initial conditions in 0.02 min and re-equilibration over
0.8 min. The total analysis time was 3 min.
The UHPLC system was hyphenated with an AB Sciex 6500 Q-Trap MS (AB Sciex, Concord, ON,
Canada) equipped with a Turbo Spray ionDrive source. MS experiments were performed in the positive
ionization mode using the selected reaction monitoring (SRM) acquisition mode. The precursor and
product ions that were monitored for each compound, as well as the respective collision energies, are
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reported in Table S1. The SRM experiments were acquired with a chromatographic time window of
60 s and a cycle time of 0.2 s. The drying gas temperature and flow rate were set at 220 ◦C and 14 L/min,
respectively. The ion source gas 1 and 2 pressures were fixed at 80 and 70 psi, respectively, with a
temperature of 350 ◦C for both.
The ion spray voltage, declustering potential, and collision cell exit potential were adjusted to 2500 V,
70 V, and 10 V, respectively. The curtain and collision gas were set at 20 psi and “medium”, respectively.
Data acquisition and instrument control were monitored using AB Sciex Analyst version 1.6.2 (AB
Sciex, Concord ON, Canada). Data treatment was performed using Skyline-daily version 4.1 (MacCoss
Lab, Seattle, WA, USA).
2.8. Calculation of Extraction Yield, Process Efficiency, and Matrix Effect
The extraction yield (EY) is described as the recovery in absence of matrix. In this study, EY was
determined by comparing a neat standard solution (2.5 µg/mL) with a neat spiked solution (2.5 µg/mL








where AUCextract is the peak area of the compound measured in the acceptor solution, AUCneat standard
the peak area of the compound in the neat standard solution, Vdonor the volume of the donor
compartment, and Vacceptor the theoretical volume recovered in the acceptor compartment.
Process efficiency (PE) describes the extraction performance in presence of matrix and is determined
by comparing a neat standard solution (2.5 µg/mL) to a spiked biological sample (2.5 µg/mL) extracted








where AUCextracted plasma is the peak area of the compound measured in the acceptor solution.
The ME is defined as the difference in signal due to ion suppression or signal enhancement. The
ME was evaluated using a method described by Matuszewski et al. [31]. In this case, the sample
was first extracted and then spiked with compounds of interest to a known final concentration. This
post-extraction spiked sample was then compared to a neat standard at the same concentration.
The ME was calculated according to Equation (3).
ME = 1−
AUCpost extraction spiked matrix
AUCneat standard
(3)
where AUCpost extraction spiked matrix corresponds to the peak area of compounds detected in a biological
matrix spiked after extraction with a known analyte concentration and AUCneat standard the peak area
of the compound at known concentration measured in neat standard.
3. Results and Discussion
TMAO, choline, betaine, l-carnitine, and deoxy-l-carnitine, known predictive biomarkers for
CVD [2], were used as model compounds. All these metabolites are very polar compounds with logP
between −4.49 and −0.93 (Table 1). Due to their very low lipophilicity, these highly polar molecules
are difficult to extract using conventional sample preparation methods such as solid-phase extraction
or reversed-phase SPE [9], which are based on the partition coefficients of analytes in two-phase
systems. Indeed, only PP has been reported as efficient sample pre-treatment for these class metabolites
so far [31,32]. PP is typically used in metabolomics, especially in large-scale studies where high
throughput is essential. Fast analytical techniques are also required, such as fast LC-MS, but may
lead to strong ME, typically for poorly-retained compounds and particularly in combination with
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straightforward sample pre-treatments [9,33]. This ME issue highlights the needs for novel sample
preparation approaches adapted to the extraction of highly polar compounds.
Table 1. Physicochemical properties of the compounds of interest.
Molecular
Weight (Da) LogP * pKa * Structure ChEBI
TMAO 75.11 −0.9 4.7
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optimized to reach the highest EY and PE while lowering ME. Because most of the compounds of 
interest are endogenously present in human plasma, dISTDs were used during the Pa-EME 
optimization step, except for bupivacaine, which is a xenobiotic compound. Based on previous work 
[20], 2-nitrophenylpentyl ether (NPPE) as SLM and 1% acetic acid (pH 2.8) as both acceptor and donor 
solutions were used as starting conditions. NPPE was selected due the expected good extraction 
recovery and low extraction variability for the selected compounds, while 1% acetic acid allowed for 
both protonation of the basic moiety and neutralization of carboxylic group of L-carnitine, deoxy-L-
carnitine and betaine. Moreover, 1% acetic acid generated a relatively low current which allowed for 
the application of higher voltages without generating excessive Joule heating. The obtained extracts 
were then analyzed using MSI-CE-MS. MSI-CE-MS consists of consecutive injections of up to seven 
different samples within the same analytical run. This leads to a significant increase in analysis 
throughput as well as decrease of analytical variability for sample injected in the same run [34–36]. 
First, the extraction voltage was investigated, since EME recoveries are known to be directly 
correlated to the electric field applied during the electroextraction process [14,29]. Figure 2 and Figure 
3 illustrate the results obtained for three compounds, i.e., choline (positively charged and polar), L-
carnitine (partially charged and polar), and bupivacaine (positively charged and non-polar). As 
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3.1. Optimization of the Parallel Electromembrane Extraction Set-Up
The EME experimental co ditions, i.e., applied voltage and sample composition, were first
optimized to reach th highest EY and PE w ile lowering ME. Because most of compounds
of interest are endogenously present in human pla ma, dISTDs were used during the Pa-EME
optimization tep, except for bupivacaine, which is a xenobiotic compound. Based on previous
work [20], 2-nitr phenylpentyl ether (NPPE) as SLM and 1% acetic a id (pH 2.8) as both acceptor
and donor solutions were used as tarting conditions. NPPE was selected due the xp cted good
extraction recovery and low extracti n vari bility for the selected compounds, ile 1% acetic acid
allowed for both protonation of the basic moiety and neutral zation of arboxylic group of l-carnitine,
deoxy-l-carnitine and betain . Moreover, 1% acetic acid generated a relat vely low current which
allowed for the application of high voltages w thout generating excessiv Joule heating. The obtained
extracts were then analyzed using MSI-CE-MS. MSI-CE-MS consists f consecutive injections of up to
seven different samples within the same analyti al run. This leads to a ignifi ant increase in analysis
throughput as well as decrease of analytical variability for sample injected in the same run [34–36].
First, the extraction voltage was investigated, since EME recoveries are known to be directly
correlated to the electric field applied during the electroextraction process [14,29]. Figures 2 and 3
illustrate the results obtained for three compounds, i.e., choline (positively charged and polar),
l-carnitine (partially charged and polar), and bupivacaine (positively charged and non-polar). As shown
in Figure 2, the EY (calculated according to Equation (1)) increased for all compounds with an increased
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extraction voltage. The gain in EY was especially important for l-carnitine, where the EY showed
a 5-fold enhancement when increasing the voltage from 75 V to 100 V. At 100 V, EYs up to 92%
were obtained, with relative standard deviations (RSDs) as low as 4%. Choline and l-carnitine are
close compounds with logD values in the same range, i.e., −4.6 and −4.8 at pH 2.8, respectively.
The difference observed in EY between both compounds might be explained by the higher molecular
charge of l-carnitine and the partial deprotonation of its carboxylic group (pKa 4.2) at pH 2.8, leading
to a decrease of its net charge [37,38] and thereby its susceptibility to electromigration. As expected,
bupivacaine was easily extracted with EY above 85% with all tested voltages, showing that the Pa-EME
setup was functioning well.
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Figure 2. Effect of applied voltage on extraction yield (n = 3). Error bars are expressed as the
standard deviations.
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Figure 3. Effect of untreated plasma content in the acceptor compartment on process efficiency (n = 3).
The highest voltage tested, i.e., 120 V, led to the highest EYs for all compounds. However,
at this voltage, a significant fluid leakage between the acceptor and donor plate was observed.
This was explained by gas production caused by electrolysis in the acceptor compartment, leading
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to an overpressure in this closed compartment and, ultimately, to the loss of the acceptor phase.
This supports the apparent higher EY that were observed due to an overestimation of the acceptor
compartment volume according to Equation (1).
Therefore, an applied voltage value of 100 V was selected for further experiments, leading to the
highest EYs without any volume loss observed.
The influence of the concentration of untreated plasma in the donor compartment on the extraction
was then investigated. As shown in Figure 3, a significant drop of PE was observed for highly polar
compounds in the presence of 10% untreated plasma or higher. The strong decrease in PE for betaine,
l-carnitine, and deoxy-l-carnitine might be explained by partial deprotonation of their carboxylic
acid group due to a pH increase in the compartment caused by addition of plasma (up to pH 4.5
with 50% of plasma) and the poor buffer capacity of acetic acid 1%. Therefore, the pH increase of the
donor compartment led to a decrease of metabolite net charge. In these conditions, TMAO and choline
remained both fully ionized, irrespective of the pH.
The observed decrease in PE for the two polar compounds might be further explained by the drastic
reduction of the electric field in the system due to the plasma ionic strength, leading to lower logD
values of polar compounds and slower migration into the SLM [39]. On the other hand, bupivacaine
was more slightly affected by this phenomenon when using up to 20% of plasma content, due to the
known high logD of non-polar compounds in the SLM. However, when using 50% of plasma content,
the important increase of ionic strength decreased the electric field, leading to a significantly lower PE
for this analyte.
Another hypothesis, i.e., the disturbance of the interface between the organic layer and the plasma
sample due to a superficial protein precipitation in this region, seems unlikely since a vortex is created
in the donor compartment thanks to the very high agitation rate (i.e., 1400 rpm). In addition, since
bupivacaine is a drug known to be 95% linked to plasmatic proteins but showed high PE values, the
protein-binding hypothesis was discarded. However, PVDF material is well-known for its very high
affinity and protein binding capacity. Therefore, this might lead to perturbation of the organic layer by
competition between the organic solvent and proteins.
Finally, as high sensitivity is essential in metabolomics, an untreated plasma content of 10% was
selected for further experiments.
In order to test our two hypotheses, we evaluated two approaches to modify the sample
composition, namely, (1) addition of an organic solvent to the sample (e.g., MeOH) to enhance the
electric field, and (2) PP prior to extraction to remove proteins.
Various proportions of MeOH were added to the donor compartment, i.e., 10%, 20%, and 50%,
but no significant difference in PE was observed (data not shown). Higher concentrations of organic
modifier were not tested to avoid possible SLM dissolution [40].
PP using TCA is known to allow for an efficient protein removal (i.e., above 99%) with a limited
dilution factor [41,42]. The PP-TCA method takes place in pure aqueous phase, showing the benefit of
avoiding the evaporation step that is necessary when using organic solvents for PP, which is favorable
for compatibility with the EME approach. Moreover, the low pH that occurs when using PP-TCA
is suitable for the extraction of cationic compounds. Therefore, PP-TCA was selected for further
investigations, in a 0.05:1 ratio (TCA:sample). After a 10-fold dilution of the precipitated plasma,
the TCA concentration was close to 30 mM, which was sufficient to obtain a pH of 2.0 and ensure
protonation of all the compounds of interest. With an applied voltage of 100 V, a high current (more than
1–2 mA/well) was observed. This relatively high current could be explained by higher conductivity
of the solution of 30 mM TCA compared to 1% acetic acid. In order to avoid the potential issues
generated by a high current, the extraction current was set to 400 µA/well to minimize electrolysis and
gas production, while maximizing both EY and PE. As presented in Figure 4, good EY (up to 75% for
polar compounds) and low variability (as low as 7%) were obtained using the optimal conditions.
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Figure 4. Influence of protein precipitation (PP) on process efficiency (PE) (n = 6). Experimental
conditions: current, 400 µA/well; extraction time, 15 min; agitation, 1400 rpm, 1% acetic acid as acceptor
compartment. TCA: trichloroacetic acid; PP-TCA: protein precipitation using trichloroacetic acid, ratio
trichloroacetic acid/sample 0.05:1 (v/v).
For all the selected compounds, similar or higher PE (up to 100%) and low variability (as low
as 2%) were obtained on protein precipitated plasma samples compared to neat solutions, e pecially
for betaine and l-carnitin where PE were 3.3 and 2.7-fold higher, respectively, when PP-TCA was
used. This increase i PE r mains unexplained and requires further investigations. Nevertheless, a PP
step appears essential prior to EME of highly polar compou ds to reduce both ionic trength and
buffer capacity of biological fluids. To assess the maximal precipitated plasma volum extractable with
the developed approach, different plasma contents, i.e., up to 50%, were evaluated. Using the same
PP-TCA method, an increase of the pre ipitated plasma c ntent into the donor compartment involved
an incr ase of TCA conc ntration, up to 150 mM. The results are summarized in Table 2.
Table 2. PE (RSD) in % (n = 6) according to the precipitated plasma amount in the sample using
the PP-TCA method and linearity ranges obtained using 30 M TCA in water. RSD: rela ive
standard deviatio s.









TMAO 104 (16) 96 (13) 94 (13) 0.27–43.19 0.997
Choline 100 (5) 84 (4) 89 (4) 1.8–286.5 0.996
Betaine 55 (12) 66 (14) 71 (9) 4.6–716.1 0.994
Deoxy-l-carnitine 84 (2) 60 (14) 60 (10) 0.1–17.6 0.997
l-carnitine 34 (14) 18 (54) 12 (6) 3.5–556.5 0.995
Bupivacaine 102 (7) 101 (3) 105 (3) n.d.
Except for L-carnitine, good PE (between 50% and 100%) values were obtained for all tested
precipitated plasma amounts. No change in PE was observed for TMAO, choline, and bupivacaine.
An increase of PE for betaine with an increased plasma content and TCA concentration was obtained,
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explained by the lower pH observed, i.e., a pH value of 1.0–1.5 with 50% of plasma and 150 mM of TCA
versus pH of 2.0 with 30 mM of TCA and 10% of plasma content. This decrease of pH induces a higher
positive net charge on betaine, leading to an increase of its electrophoretic mobility. Nevertheless, the
decrease in PE observed for deoxy-l-carnitine and carnitine remain unexplained but might be the
consequence of stability issues of these metabolites in highly acidic conditions (pH ~1).
Finally, the linear response function of the developed method was evaluated. For this purpose,
a fast LC-MS/MS method was used to be in similar conditions as what is observed in the context
of large cohort studies with thousands of samples. The calibration curve was plotted using ratios
of non-deuterated compounds and dISTDs in a neat solution. Calibration samples with increasing
concentrations of TMAO, choline, betaine, l-carnitine and deoxy-l-carnitine (Table 2) were made and
mixed to constant concentrations of their dISTD in 30 mM TCA, to mimic EME conditions of the donor
compartment composition. These calibration samples were extracted using the optimized Pa-EME
setup and the selected experimental parameters (i.e., 400 µA/well, 15 min, 1400 rpm). As shown in
Table 2, a linear response function (R2 > 0.995) was obtained on concentration ranges of two orders of
magnitude for all compounds of interest (Figure S1).
3.2. Evaluation of Matrix Effects
The ME were evaluated for the developed Pa-EME set-up in combination with fast-LC-MS/MS.
The observed ME when using a conventional PP-MeOH were compared to the method combining
PP-TCA and Pa-EME. For all these experiments, the same amount of untreated plasma concentration
was used, i.e., 10 µL of untreated plasma for 100 µL of precipitated plasma for PP-MeOH and 30 µL
of untreated plasma for 300 µL of donor solution for EME, respectively, leading in both case to an
equivalent of 10% of untreated plasma after PP. As shown in Figure 5, lower MEs were observed
using the combination of PP-TCA and Pa-EME. Compared to the conventional PP-MeOH approach,
a noticeable decreased ME was observed, especially in the case of TMAO and betaine where the
observed ME was 2-fold lower with the combined approach versus MeOH-PP alone. This decrease
might be explained by the cationic selectivity of EME and efficient salt removal.Metabolites 2020, 10, 4 12 of 17 
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Along with the decrease in ME and high PE, a 2.9-fold increase of peak intensity was observed with
EME compared to PP-MeOH for TMAO. The sensitivity observed for choline and deoxy-l-carnitine
was not significantly impacted, with an increased factor of 1.2 and 1.1, respectively. With same signal
intensity, the lower ME observed for betaine compared to PP-MEOH compensated for the low PE of
this compound (i.e., 55%). Finally, l-carnitine, which was the compound with the lower PE (i.e., 34%),
showed reduced ME but was detected with a signal intensity 0.6-fold lower than with PP-MeOH.
3.3. Application to Metabolomics Studies
The potential of the developed Pa-EME set-up for large scale metabolomics studies has been
investigated by correlating the data obtained with this optimized extraction method (combination
of PP-TCA+EME) versus a typically used sample clean-up, i.e., PP-MeOH, on a set of 40 human
plasma samples.
Due to limited volume of plasma available (ca. 25µL), the developed PP-TCA was first downscaled.
This adjusted PP-TCA method led to an equivalent of 5% of untreated plasma after PP. The downscaled
method led to similar extraction performance compared to the conventional PP-TCA (data not shown),
and was therefore used for subsequent experiments.
As shown in Figure 6, excellent correlations were obtained between the two evaluated sample
preparation approaches for TMAO, choline, l-carnitine, and deoxy-l-carnitine, with correlation
coefficients (R) between 0.88 and 0.98. In addition, the linear models are highly significant, with p-values
between 1.4 × 10−14 and 1.3 × 10−32. These results highlight the relevance of the developed Pa-EME
method in comparison with gold standard methods used for sample preparation in metabolomics.
However, a poor correlation was observed for betaine (R = 0.46), probably due to a contamination of
the milliQ water used for preparation of acceptor and donor solution with a compound detected in the
same SRM transition as betaine.
During the analysis of these clinical samples, an unexpected boiling and loss of acceptor
compartment was observed for many samples during the EME process. This unexpected phenomenon
was likely explained by the differences in plasma composition. Indeed, the optimization phase was
carried out using the same sample split in six aliquots which were simultaneously extracted using
Pa-EME. Therefore, the total applied current (2.4 mA) was equally distributed over the six wells, leading
to a current of 400 µA/well. No boiling or loss of acceptor phase was observed during the optimization
process. However, with a parallel extraction of six different plasma samples, the applied current was
not uniformly distributed over the wells. Indeed, due to small differences of sample composition (e.g.,
ionic strength, residual proteins, etc.), plasma samples possess different conductivities. According to
Kirchhoff’s current law, these different conductivities lead to different current in every parallel circuit.
Consequently, several samples were subjected to currents lower than 400 µA and other samples to
a current above this limit, the latter leading to boiling and loss of acceptor volume. However, this
variability was successfully corrected using a dISTD for each compounds of interest, as shown by
the good correlation obtained with PP-MeOH (Figure 6). A solution to circumvent this issue could
be to use lower currents to stay below the limit of 400 µA/well, but this solution requires enhanced
extraction times or would lead to lower PE.
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and PP-MeOH (y-axis). 95 % confidence intervals were calculated using Pearson correlation. dISTD:
deuterated internal standard.
4. Conclusions
This study demonstrated the power of EME approaches for the extraction of highly polar
compounds from biological fluids and its potential for metabolomics studies. In this study, we
presented an optimized Pa-EME method for the efficient extraction of highly polar compounds from
plasma. The developed Pa-EME method involves a PP step using TCA before the actual EME process;
this is an essential step to reduce the buffer capacity of plasma, and additionally to avoid possible
interferences with the PVDF membrane. We demonstrated that the combination of PP-TCA with
Pa-EME allowed for high PE (up to 100%) as well as low variabilities (RSD as low as 7%) for the
extraction of selected highly polar compounds from plasma samples. Moreover, the PP-TCA-Pa-EME
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set-up led to decreased ME in comparison to conventional PP-MeOH when using fast chromatography
(up to 2-fold matrix effect reduction for TMAO and betaine). A 3-fold gain in sensitivity was observed
for TMAO with PP-TCA-Pa-EME compared to PP-MeOH. Similar sensitivity was obtained for choline,
betaine, and deoxy-l-carnitine. However, using PP-TCA-PaEME, l-carnitine presented a decrease of
sensitivity in comparison with PP-MeOH due to incomplete extraction. This poor sensitivity could
be nevertheless improved with further experiments and the development of a new Pa-EME set-up
for higher enrichment with favorable acceptor/donor volume ratio. The developed method showed
a linear response function (R2 between 0.994 and 0.997) of more than two orders of concentration
magnitude for all the metabolites of interest.
Finally, the developed PP-TCA-Pa-EME method was compared to PP-MeOH using 40
different plasma samples. The influence of sample conductivity, which is a common concern in
electromigration-based sample pre-treatment, was highlighted but was fully compensated using
dISTDs for each compound. Overall, the combination of PP-TCA and EME showed excellent
correlation with the conventional PP-MeOH.
The great potential of electromembrane extraction in bioanalysis is highlighted by its analytical
merit in terms of high recovery (up to 100%) and low variability (down to 7%) of highly polar
metabolites from a complex matrix such as plasma, a significant reduction of the matrix effect, and the
strong correlation to gold standard sample preparation practices in metabolomics.
The development of a new Pa-EME device to further reach higher enrichment factors for such
metabolites will represent the next logical step for application of this method to state-of-the-art
metabolomics-based analysis.
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Abbreviations
CVD cardiovascular disease
CE-MS capillary electrophoresis–mass spectrometry




Fast-LC-MS/MS fast liquid chromatography–tandem mass spectrometry
HILIC hydrophilic interaction chromatography
ME matrix effect
MSI-CE-MS multisegment injection–capillary electrophoresis–mass spectrometry
NPPE 2-nitrophenylpentyl ether
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MeCN acetonitrile
MeOH methanol
Pa-EME parallel electromembrane extraction
PE process efficiency
PEEK polyether ether ketone
PP protein precipitation
PP-MeOH protein precipitation using methanol, ratio methanol/sample 9:1 (v/v)
PP-TCA
protein precipitation using trichloroacetic acid, ratio trichloroacetic acid/sample 0.05:1
(v/v)
PVDF polyvinyldifluoride
SLM supported liquid membrane
SRM selected reaction monitoring
TCA trichloroacetic acid
TMAO trimethylamine N-oxide
UHPLC ultra-high pressure liquid chromatography
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